跳至主要内容
临床试验/IRCT2016040318124N3
IRCT2016040318124N3已完成3 期

Compare the therapeutic effect of Melatonin, Metformin and Vitamin E on liver function, sugar and lipid factors in patients with non-alcoholic fatty liver disease (NAFLD) dietary regimen

Vice chancellor for research, Qazvin University of Medical Sciences0 个研究点目标入组 90 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
90

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20 years 至 50 years(—)
性别
All

入选标准

  • Having non-alcoholic fatty liver disease (NAFLD) without other liver diseases.
  • Exclusion criteria: Alcohol consumption of more than 20 gr per day for women or more than 30 gr in men for at least 3 consecutive months during a recent 5 year period, Patients with autoimmune hepatitis, hepatitis B, hepatitis C and other chronic liver diseases, Patients with heart failure (New York Heart Association class II to IV), Patients taking drugs that cause osteo-hepatitis like fibrates, statins, NSAID, Amiodarone, and Tamoxifen, Patients with proven diabetes mellitus under medical therapy, Patients receiving vitamin C, zinc and selenium or antioxidant agents during a recent three months, Patients with kidney disease and kidney failure or any patients with GFR less than 60.

排除标准

  • 未提供

研究者

发起方
Vice chancellor for research, Qazvin University of Medical Sciences

相似试验